Zovia D

IV Injection or Infusion
Opsonin Pharma Ltd.
100 ml vial: ৳ 350.00
Indications

Approved Medical Uses:

  • Prevention and treatment of vitamin deficiencies in patients unable to maintain adequate oral intake due to illness, surgery, trauma, or malabsorption.
  • Parenteral nutrition support in patients receiving total parenteral nutrition (TPN), to fulfill daily vitamin requirements.
  • Adjunctive therapy in conditions such as alcoholism, chronic liver disease, or gastrointestinal disorders where absorption is impaired.
  • Post-operative nutritional support, including patients recovering from major surgery or burns.
  • Prolonged fasting, starvation, or cachexia in critically ill patients.

Clinically Accepted Off-label Uses:

  • Supportive therapy in cancer patients receiving chemotherapy or radiotherapy.
  • Vitamin supplementation in elderly, frail, or immobilized patients with poor nutritional status.
  • Repletion of vitamin levels in ICU or emergency settings, especially in multi-organ failure or septic shock.
Dosage & Administration

Route of Administration: Intravenous (IV) infusion only

Adults:

  • Recommended dose: One IV infusion containing multivitamins + 5% dextrose daily
  • Usual volume: 500 mL to 1000 mL infused over 6–8 hours
  • Adjust based on clinical condition, fluid status, and vitamin requirements

Pediatric Patients:

  • Neonates and Infants: Dose individualized based on weight and clinical need. Typical volume: 100–250 mL/day
  • Children: 250–500 mL/day infused over 6–12 hours
  • Always use pediatric-specific multivitamin preparations

Elderly:

  • Same as adult dosing. Monitor for comorbidities (e.g., renal or cardiac impairment) requiring slower infusion or dose adjustments

Renal Impairment:

  • Adjust dose to avoid accumulation of fat-soluble vitamins (particularly vitamins A and D)
  • Monitor fluid status and electrolytes carefully

Hepatic Impairment:

  • Use with caution; reduce doses of hepatically metabolized vitamins (e.g., Vitamin A)
  • Monitor liver function tests during prolonged use

Administration Instructions:

  • Administer slowly via controlled infusion pump
  • Do not mix with other medications unless compatibility is confirmed
  • Use immediately after preparation; discard unused portion
Mechanism of Action (MOA)

Multivitamin [Water & Fat Soluble] + 5% Dextrose provides essential vitamins and carbohydrates required for normal metabolic function and cellular repair. The water-soluble vitamins (e.g., B-complex and C) act as cofactors in enzymatic reactions related to energy metabolism, hematopoiesis, and neurotransmitter synthesis. The fat-soluble vitamins (A, D, E, and K) play critical roles in vision, bone mineralization, antioxidant defense, and blood coagulation. The addition of 5% dextrose supplies a readily available source of glucose, preventing catabolism, supporting cellular energy needs, and promoting vitamin utilization in malnourished or acutely ill patients.

Pharmacokinetics

Absorption: Not applicable (IV administration bypasses GI absorption)

Distribution:

  • Water-soluble vitamins distribute freely in plasma and tissues, with minimal storage
  • Fat-soluble vitamins accumulate in liver and adipose tissue
  • Dextrose distributes throughout total body water

Metabolism:

  • B vitamins and Vitamin C are metabolized in the liver and tissues
  • Vitamins A, D, E, and K undergo hepatic metabolism
  • Dextrose is metabolized via glycolysis and enters the Krebs cycle

Elimination:

  • Water-soluble vitamins: Renally excreted; excess eliminated rapidly
  • Fat-soluble vitamins: Slow elimination; can accumulate with prolonged use
  • Dextrose: Metabolized to CO₂ and water

Half-life:

  • Water-soluble vitamins: Hours to a day
  • Fat-soluble vitamins: Days to weeks
  • Dextrose: Very short, rapidly utilized

Bioavailability: 100% via IV route

Pregnancy Category & Lactation

Pregnancy:

  • No specific FDA pregnancy category for this combination.
  • Generally considered safe when used at therapeutic doses.
  • Caution with Vitamin A, as high doses may be teratogenic.

Lactation:

  • Most vitamins are excreted into breast milk.
  • Safe when used within normal therapeutic ranges.
  • Monitor infant for signs of vitamin excess if high-dose therapy is given to mother.
Therapeutic Class
  • Primary Class: Parenteral Multivitamin Supplement
  • Subclass: Water- and Fat-soluble Vitamin Combination with Dextrose Carrier
Contraindications
  • Known hypersensitivity to any vitamin component or formulation excipients
  • Hypervitaminosis A or D
  • Severe hepatic impairment or active liver disease (risk of vitamin toxicity)
  • Fluid overload or pulmonary edema (due to dextrose infusion)
  • Glucose intolerance or uncontrolled hyperglycemia
Warnings & Precautions
  • Monitor closely in renal or hepatic impairment; adjust doses of fat-soluble vitamins
  • Vitamin A toxicity risk with prolonged or high-dose therapy
  • Hyperglycemia risk in diabetic patients due to 5% dextrose content
  • Risk of anaphylaxis or hypersensitivity, especially from thiamine or preservatives
  • Monitor liver enzymes, renal function, glucose levels, and vitamin levels during long-term use
  • Avoid rapid infusion to reduce risk of metabolic disturbances
Side Effects

Common Adverse Effects:

  • Infusion site pain or thrombophlebitis
  • Nausea, metallic taste
  • Mild rash or flushing

Uncommon to Rare:

  • Headache, dizziness
  • Diarrhea or abdominal discomfort
  • Elevated liver enzymes

Serious or Rare Effects:

  • Anaphylactic reactions
  • Hypervitaminosis A or D with prolonged use
  • Hepatic dysfunction
  • Electrolyte imbalance or fluid overload
Drug Interactions
  • Levodopa: High doses of Vitamin B6 may reduce its efficacy
  • Warfarin: Vitamin K can antagonize anticoagulant effect
  • Orlistat, Cholestyramine: Reduce absorption of fat-soluble vitamins
  • Antibiotics (e.g., tetracycline): May bind with vitamins and reduce their absorption
  • Enzyme interaction: Some fat-soluble vitamins are metabolized via CYP450 enzymes (especially CYP3A4); caution with inducers/inhibitors
Recent Updates or Guidelines
  • WHO (2024) and ASPEN recommend routine parenteral multivitamin use in all patients receiving TPN to prevent deficiencies
  • EMA advises regular monitoring of vitamin A levels in long-term parenteral nutrition
  • New preservative-free formulations have been developed to reduce risk of hypersensitivity reactions
  • Clinical guidelines updated to prioritize early micronutrient support in ICU and surgical patients
Storage Conditions
  • Store below 25°C
  • Protect from light (especially for vitamins A, D, E, and K)
  • Do not freeze
  • Use immediately after opening or reconstitution
  • Discard any unused portion after 24 hours
  • For compounded solutions: Follow specific manufacturer instructions for storage and handling
Available Brand Names